Skip to main content
. 2021 Aug 2;13:653694. doi: 10.3389/fnagi.2021.653694

TABLE 3.

Frequencies and percentages of neurological disease, COVID-19 severity, comorbidities, and detectable virus in CSF by sex.

Variable n Female Male Not specified
Neurological disease category 510
Cerebrovascular disease 68 (39%) 133 (48%) 56 (98%)
CNS inflammatory disease 20 (11%) 26 (9%) 0 (0%)
Demyelinating disease 6 (3%) 8 (3%) 1 (2%)
Encephalopathy 25 (14%) 32 (12%) 0 (0%)
Taste/smell disorders 21 (12%) 15 (5%) 0 (0%)
Peripheral neuropathy 19 (11%) 44 (16%) 0 (0%)
Other 16 (9%) 20 (7%) 0 (0%)
COVID-19 severity 495
Asymptomatic 20 (12%) 16 (6%) 3 (5%)
Mild 21 (12%) 44 (16%) 2 (4%)
Moderate 61 (36%) 73 (27%) 10 (18%)
Severe 31 (18%) 67 (25%) 35 (61%)
Critical 37 (22%) 68 (25%) 7 (12%)
Comorbidities (reclassified) 363
None 42 (39%) 78 (37%) 11 (23%)
DM 2 (2%) 17 (8%) 2 (4%)
DM, lipid disorder 1 (1%) 1 (0%) 2 (4%)
DM, obesity 1 (1%) 0 (0%) 0 (0%)
DM, other 1 (1%) 1 (0%) 1 (2%)
HTN 20 (19%) 27 (13%) 8 (17%)
HTN, DM 5 (5%) 24 (11%) 0 (0%)
HTN, DM, lipid disorder 1 (1%) 3 (1%) 5 (11%)
HTN, DM, lipid disorder, other 0 (0%) 1 (0%) 3 (6%)
HTN, DM, obesity 1 (1%) 4 (2%) 0 (0%)
HTN, DM, obesity, lipid disorder, other 1 (1%) 0 (0%) 0 (0%)
HTN, DM, obesity, other 1 (1%) 2 (1%) 0 (0%)
HTN, DM, other 2 (2%) 6 (3%) 0 (0%)
HTN, lipid disorder 1 (1%) 10 (5%) 5 (11%)
HTN, lipid disorder, other 3 (3%) 0 (0%) 2 (4%)
HTN, obesity 1 (1%) 4 (2%) 0 (0%)
HTN, obesity, lipid disorder 0 (0%) 1 (0%) 0 (0%)
HTN, obesity, lipid disorder, other 1 (1%) 0 (0%) 0 (0%)
HTN, obesity, other 0 (0%) 1 (0%) 0 (0%)
HTN, other 5 (5%) 13 (6%) 4 (9%)
Lipid disorder 1 (1%) 1 (0%) 3 (6%)
Lipid disorder, other 0 (0%) 1 (0%) 0 (0%)
Obesity 4 (4%) 5 (2%) 1 (2%)
Obesity, other 5 (5%) 0 (0%) 0 (0%)
Other 8 (7%) 9 (4%) 0 (0%)
Virus in CSF 122
No 50 (98%) 67 (96%) 1 (100%)
Yes 1 (2%) 3 (4%) 0 (0%)

Due to rounding errors, column wise percentages may not equal 100%. CNS, Central nervous system; DM, Diabetes mellitus; HTN, Hypertension; CSF, Cerebral spinal fluid.